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Abstract   
This research plan is to examine the cardioprotective effects of bioactive 
diosgenin molecules isolated from Dioscorea plants on Isoproterenol (ISO)-
induced myocardial infarction. Male albino Wistar rats were treated with 
D.bullifera and Diosgenin (20 mg/kg) daily for four weeks. After the 
experiment, the animals were injected with ISO (85 mg/kg) subcutaneously at 
24 hour intervals for two days. The results describe the myocardial injury 
induced by ISO, which is manifested as an increase in serum cardiac marker 
enzymes CK-MB, C.K.P., G.O.T., and G.P.T. And L.D.H. and essential 
oxidative stress markers, such as LPO and G.S.H. In addition, significant 
increases in serum total cholesterol, triglycerides, and low-density lipoprotein 
cholesterol levels were also observed, while serum high-density lipoprotein 
cholesterol levels were reduced. Histopathological studies are also related to 
the above parameters. In addition to cardiac markers, lipid peroxidation levels 
in plasma and heart are also elevated. However, antioxidant enzymes such as 
glutathione peroxidase (G.P.X.), catalase, S.O.D. and reduced glutathione 
(G.S.T.) are significantly reduced in the heart after ISO-induced myocardial 
infarction. These findings summarized the cardioprotective effects of diosgenin 
and dioscorea on cardiac markers and antioxidant activity. 
 
Keywords: Myocardial infarction; Isoproterenol; Lipid profile; Cardiac 
markers; Diosgenin. 
Abbreviations:  
G.O.T., glutamic oxaloacetic transaminase, G.P.T., glutamic pyruvic 
transaminase, G.S.H., reduced glutathione, G.P.X., glutathione peroxidase, 
G.S.T., glutathione s-transferase, G.S.H., reduced glutathione, L.D.H., lactate 
dehydrogenase, ISO, Isoproterenol, LPO, lipid peroxidation, S.O.D., 
superoxide dismutase, HDL, high-density lipoprotein, LDL, low-density 
lipoprotein. 
Introduction 
Worldwide, myocardial infarction (MI) is the leading cause of death in humans. Myocardial infarction is a 
major health problem and a cause of death in developed and developing countries. According to the 
World Health Organization survey report, by 2020, heart disease and stroke will become the leading 
causes of death worldwide. Animal models of isoproterenol-induced myocardial infarction have been 
used to evaluate cardiac marker enzymes (Farvinet al. 2006 and Wexler BC., 1978). Isoproterenol (ISO) is 
a synthetic catecholamine and β-adrenergic agonist that can cause severe oxidative stress in the heart 
muscle, leading to an infarction similar to myocardial necrosis. It also knows how to stimulate lipid 
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peroxidation and generate free radicals to prevent uncompetitive necrosis of the heart membrane. The 
new lead molecule is guaranteed to cure ischemic heart disease. (Kasik and Prince 2006). "Although 
many conventional drugs can be used to prevent coronary artery disease, their effects are usually limited 
due to their side effects" (Subasini et al. 2009). In addition, the presence of alkaloids, tannins, plant 
sterols, flavonoids, and saponins have been exposed to reduce LDLC and increase HDL levels. Regular 
physical exercise can lower low-density lipoprotein cholesterol and increase high-density lipoprotein 
cholesterol, but it has been shown to improve cardiovascular health through other mechanisms and is the 
cornerstone of weight loss. Generally speaking, through weight loss, regular exercise, moderate alcohol 
consumption and lower dietary cholesterol, such as eating red meat, LDLC can be reduced by about 10-
15% (Kumar, 2015). 
D. bulbifera L. (D.B.), belonging to the family of Dioscoreaceae. D.B. generally called air yam or air 
potato or bitter yam. It is a climber plant with tuberous roots. D.B. has been commonly used in the 
Chinese system of medicine as an appreciated herb in the process of reconstruction and upholding kidney 
stone related problems. This herb was also initiated to have a valuable effect in treating diseases of the 
lungs and spleen and many types of dysentery, diarrhoea, fruitful digestion and metabolism. In Asia, this 
herb has been highly suggested for treating metabolic disorders (Ahmed et al. 2009). It has been 
conventionally used to lower the hyperglycemic index, providing a more continuous form of energy and 
better defence against obesity, dyslipidemia and diabetes. However, this property has not yet been 
systematically proven (Saravanan et al. 2011). Some literature reports are accessible on D. bulbifera use 
in diabetes mellitus and other related metabolic disorders, but not technically authenticated study has been 
carried out to justify its potential in experimental cardioprotection from ischemic heart diseases. There are 
several studies on tuber medicinal plants, the antioxidant activity of tubers, and the stems and leaves used 
in traditional medicine used in the evaluation of tuber animal models with cardioprotective effects. 
However, this study plans to examine the cardioprotective effects of ISO-induced diosgenin using cardiac 
markers in serum and heart tissue and antioxidant activities in rats. 
 
Methods and Materials        
Chemicals 
Isoproterenol purchased from the Sigma Chemical Company, St. Louis, MO, U.S.A. All the 
chemicals and other reagents used analytical grade. 
 
Plant materials 
D. bulbifera (tubers) are identified by Rabinat Herbarium, St. Joseph College, Trichy, Palayamkottai 
and Botanical survey CCRAS Unit, Chennai, Tamil Nadu, India. The plant herbarium are deposited in the 
department of  CARISM herbarium, and it was kept as DB-0062-2009. Hydroalcoholic extract of D. 
bulbifera screened for medicinally active constituents through the different qualitative and quantitative 
chemical methods. Hydroalcoholic extract of D.bulbifera gave positive test for terpenes, steroids, 
isoflavonoids, saponins and glycosides. Thin-layer chromatography of the hydroalcoholic extract of D. 
bublifera exposed purple, red, orange and green spots by Liebermann's test for steroids are present in the 
hydroalcoholic extract. D.bulbifera tubers were collected and authenticated by the pharmacognostic 
observations (Subasini et al., 2009) Fig 1 (A & B) and were selected for the new lead molecules for the 
management of coronary artery disease.  
Extraction 
The tubers of D. bulbifera were harvested and dried in the shade for 15 days. They are roughly course 
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powdered with a mixer blender. The dried tubers were extracted with water and alcohol by the cold 
osmosis method. The extract was then dried under a vacuum and stored in the refrigerator. The 
preparation of diosgenin was carried out according to the method of (Ghosh 2013). Narula et al. (2007), 
high content of diosgenin was found in D. bulbifera L., which is a potentially active biomolecule of 
diosgenin. Zhang et al. (2006) reported that diosgenin has powerful hypoglycemic and cholesterol-
lowering activities.  
 
Experimental animals 
Thirty-six male albino Wistar rats weighing about 150-200 g were randomly selected. They are 
placed under standard laboratory conditions, room temperature (21ºC ± 2ºC) and 55-60 % relative 
humidity. They are fed a standard diet, including pellets and ad libitum drinking water. The study was 
conducted in accordance with CPCSEA guidelines and was approved by the Institutional Animal Ethics 
Committee (IAEC) of the SwamyVivekandha School of Pharmacy (Proposal No.: SVCP / IAEC / Pharm / 
07/2012). 
 
Experimental protocol for Isoproterenol (ISO) induced myocardial infarction 
Male Wistar rats (weight 150-200 g) were randomly divided into six groups, each group containing six 
animals. The experimental myocardial infarction consisted of two subcutaneous injections of 85 mg/kg of 
Isoproterenol dissolved in physiological saline at 24-hour intervals. At the end of the 30th day, take the 
D.B. extract and diosgenin 30 minutes later. On day 31st day (24 hours after the first dose of ISO), the 
second dose of ISO was given. 
Group 1: Received vehicle 5% Tween 80 in saline p.o.,  - normal control 
Group 2: Received 85 mg/kg of Isoproterenol in sc.  -  disease control. 
Group 3: Received 100 mg/kg of D.B. extract in oral (two times a day every 12 hrs) 
Group 4: Received 200 mg/kg of D.B. extract by the oral route 
Group 5: Received 10 mg/kg of diosgenin by the oral route via feeding tube. 
Group 6: Received diosgenin 20 mg/kg + ISO treated; injected with Isoproterenol at 1 mg/kg body weight 
and two times a day for the period of one month. Diosgenin was administered to the 5th and 6th group of 
animals three days before to Isoproterenol.  
After administration of 2nd dose of ISO, animals are fasted for 24 hours and at the end of 24thhour 
(i.e. 48 hours after the administration of 1stdose of ISO). The experiment was completed after one month, 
and then after overnight fasting, the animals are killed by cervical decapitation.  
 
Biochemical parameters 
 Blood was collected in a test tube, the homogenate was centrifuged at 3000 rpm for 15 minutes, and the 
supernatant was used for various biochemical parameters. For all biochemical evaluations in the heart, a 
homogenate of myocardial tissue was prepared in 10 % phosphate-buffered saline. Take 10 % of the 
cardiac tissue in a tissue homogenizer and prepare it in a 0.1 M Tris HCl buffer solution (pH 7.4). 
Estimate levels of lipid peroxidation (L.P.O) (Okhawa et al. 1979), lactate dehydrogenase (L.D.H.) (King, 
1965a), glutamate oxaloacetate aminotransferase (G.O.T) and glutamate pyruvate aminotransferase 
(G.P.T) (Mohun and Cook, 1957), glutathione peroxidase (GPx) (Rotruck et al. 1973), reduced 
glutathione (G.S.H.) (Ellman, 1959) and glutathione (G.S.T.) (Moron, 1979). Catalase activity was 
estimated by (Sinha 1972) superoxide dismutase (S.O.D.) based on (Kakkar et al. 1984), using standard 
Spinreact kits to analyze CK-MB estimates and creatine phosphokinase estimates (C.P.K., EC2. 7.3 .2) 
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(Okinaka et al. 1961). 
Estimation of serum cholesterol 
Serum cholesterol and triglycerides were predictable using standard cholesterol estimation Randox 
kit (Catalogue no. CH 201, TR 1697- Zlatkis et al. 1953). Serum HDL-cholesterol was projected from 
Randox (Catalogue no. CH 204).  
Statistical Analysis 
The results were statistically presented here as the means ± means by one-way Analysis of 
Variance (ANOVA), and groups were compared by Duncan Multiple Range Test (DMRT) used by SPSS 
software version 12.0. A value of p<0.05 was considered statistically significant.  
 
Result and Discussion 
Cardio protective potential of D. bulbifera 
Myocardial infarction is commonly induced by different small animals such as mice, rats and rabbits 
of invasive methods. In this research work, the myocardial muscles of the heart induced by the 
administration of Isoproterenol, this chemical compound used for arterial and bronchial smooth muscles 
dilatation. It also affects the heart by increasing contractility and stroke volume. Evaluating the 
cardioprotective effect of D. bulbifera using different groups of rats were treated with D.bulbifera (D.B.) 

















Fig. 1: D.bulbifera and its tubers. Fig (A) Exomorphic features of bulbs  
                                                       Fig (B) Twining perennial herb 
 
Effect of D.B. & diosgenin on cardiac markers 
Effect of D.B and diosgenin on cardiac enzymes like CK-MB, C.P.K., L.D.H., G.O.T., G.P.T. 
activities in Isoproterenol induced Myocardial infarction rats. Therefore, examining the D.B and 
diosgenin could reorganize the ISO induced myocardial damage. Myocardium muscles of the heart 
having an elevated concentration of proteins and enzymes, which are released into the extracellular fluid. 
In this research, D.B. and diosgenin have inhibited the release of cardiac marker enzymes in the serum 
compared with ISO treated rats.  
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The activity of CK-MB, C.P.K., L.D.H., G.O.T., G.P.T. and alkaline phosphatase (A.L.P.) is in the 
heart tissue of the diseased rats in the second group was significantly reduced, and the serum level was 
increased (p<0.05, Table 1 and Table 2). Sathish et al. (2003) also tested these diagnostic markers in ISO-
treated rats.  Ghosh et al. (2013) stated that the level of enzymes in the serum is directly proportional to 
the number of necrotic cells in the damaged heart tissue. Heart muscle contains many proteins and 
enzymes that, once damaged, are released into the extracellular fluid and measured as potential marker 
enzymes. These enzymes, mainly CK-MB, C.P.K., L.D.H., G.O.T., G.P.T., are released into the 
circulation due to myocardial degeneration and myocardial cell necrosis (Wexler and Greenberg, 1978). 
ISO causes a series of metabolic events in myocardial tissue, beginning with anaerobic glycolysis, 
inhibiting the ATP-dependent transport process in the cell membrane, electrolyte transfer, cell oedema, 
and finally loss of membrane integrity. cellular (Saravanan et al., 2011). This leads to the release of these 
specific marker enzymes from the heart.- 
In the present study, D.B. and diosgenin have prevented the acute release of diagnostic marker 
enzymes in the serum as compared with ISO treated group of rats. The important boost of investigative 
markers in ISO treated rats has also been reported by Sathish et al. (2003). The activity of CK-MB, 
C.P.K., L.D.H., G.O.T., G.P.T. and alkaline phosphatase (A.L.P.) is observed to be decreased significantly 
in heart tissue and increased in serum of diseased group II of animals compared to the normal group of 
animals (p<0.05, Table 1 & 2). The quantity of necrotic cells in the injured cardiac tissue is directly 
proportional to the number of enzymes present in the serum (Ghosh et al., 2013). In comparison to the 
diseased group II of animals, pretreatment with diosgenin reduced the activity of these enzymes in serum 
while increasing it in heart tissue (p<0.05, Table 1).  
A useful cardiac marker for myocardial infarction is serum CK-MB (Suchalatha et al., 2004). Table 1 
shows that the serum CK-MB level increases (p<0.05) in diseased conditions. Similar results have been 
observed by Vimal & Devaki (2004). In treatment animals with diosgenin, it is found to decrease 
significantly (p<0.05) at both doses. The percentage of decrease is calculated as 45 % at 10 mg/kg b.wt 
and 48.4 % at 20 mg/kg b.wt., respectively. But, treating animals with diosgenin serum CK-MB level is 
found to decrease and seem to reach the normal level at a lower dose of 10 mg/kg b.wt. itself. The same 
value also maintains in the dose of 20 mg/kg b.wt. of diosgenin. 
 
Table 1. Effect of D.B. &diosgenin on cardiac markers in ISO induced MI in rats 
Groups CK-MB CK Serum CK Heart LDH Serum LDH 
Heart 
Normal 54.9 ± 3.1a 1.53± 0.14a 300.9±7.2a 3.6±0.6a 44.6±4.3b 
ISO 308.4±91.3b 3.8± 1.14b 170.3±14.8b 7.0±1.3b 24.1±1.9a 
DB(100)+ISO 172.0±55.9ab 2.08± 0.45a 295.2±28.4a 5.1±0.02ab 32.3±4.9ab 
DB(200)+ISO 159.0±6.92ab 1.90± 0.48a 276.7± 15.8a 4.2±0.9ab 37.9±6.9ab 
DG 10 (mg/kg) 51.6 ± 3.6a 2.16± 0.56a 272.9± 24.0a 5.2±0.2ab 35.3±7.1ab 
DG 20 (mg/kg) 53.1±35.0a 1.6 ± 0.6a 266.8± 36.2a 4.3±0.2ab 39.6±6.2ab 
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Effect of D.B. & diosgenin on glutathione and lipid peroxidation 
When administering D.B and diosgenin, the serum increased the levels of oxidative stress markers, 
such as L.P.O, G.S..H and G.P.X compared to control animals. It was observed in the heart and serum of 
rats of disease group II (Table 3. p <0.05). It was observed that the rats previously treated with ISO and 
Diosgenin (groups III, IV and V) significantly reduced the levels of these markers (p <0.05, Table 3) 
compared to the diseased rats of group II. Subasini et al. (2014) explained that "ISO undergoes oxidation 
that leads to the formation of superoxide anions, and the propagation of the chain reaction leads to 
R.O.S." In this study, the activity of enzymatic antioxidants such as S.O.D., catalase, GPx, and G.S.T. (p 
<0.05, Table 4) Compared to normal rats in serum and cardiac tissue in the diseased heart of rats. 
Regarding the treatment of D.B. animals and diosgenin, the activity of antioxidant enzymes and other 
non-enzymatic antioxidants was observed to increase in a dose-dependent manner in animals of groups 
III, IV, and V against diseased animals of group II. Note that the evidence that ISO induces increased 
oxidative stress markers in rats may be due to the production of free radicals. 
 
Table 3. Effect of D.B. &diosgenin on glutathione and lipid peroxidation in ISO induced MI in rats 
Groups LPO  LPO  G.S.H.  G.S.H.  GPx GPx 
Values are mean ± S.D. (n=6). A significant difference was observed between different groups 
using One Way ANOVA followed by DMRT. Values with different letters like a,b, ab of the 
same column are differed significantly (p<0.05).Note: Activity of creatine kinase(C.K.), 
L.D.H., are represented as nM of phosphate liberated/min/mg of protein, nM of pyruvate 
liberated /min/mg of protein, µM of pyruvate formed/min/mg of protein, µM of pyruvate 
formed/min/mg of protein. 













Normal 5.7±1.1a 132.1±3.1b 7.1±0.9a 175.9±10.4b 225.2±10.5a 10.6±1.5b 
ISO 8.5±0.7b 105.8±4.5a 10.5±0.2c 137.1± 5.0a 181.1±7.6c 19.7±2.3a 
DB(100)+ISO 6.9±0.4ab 114.0±9.5ab 9.5±0.5bc 148.9±9.2ab 186.9±10.7bc 18.6±1.9a 
DB(200)+ISO 6.7±0.7ab 119.2±8.4ab 8.6±1.1abc 150.4±9.3ab 200.1±10.7bc 17.2±0.6ab 
DG 10 mg/kg 7.9±0.5ab 110.2±8.4ab 9.3±0.6bc 141.8±11.3a 183.7±4.9abc 15.5±0.8a 
DG 20 mg/kg 6.4±0.7ab 121.4±9.7ab 7.7±0.2ab 151.2±12.5ab 193.2±3.5ab 14.1±1.3ab 
Values are mean ± S.D. (n=6). A significant difference was observed between different groups using 
One Way ANOVA followed by DMRT. Values with different letters like a,b,c, ab of the same column 
are differed significantly (p<0.05).Note: Activity of SGOT, SGPT and alkaline phosphatase(A.L.P.) 
are represented as nM of phosphate liberated/min/mg of protein, nM of pyruvate liberated /min/mg of 
protein, µM of pyruvate formed/min/mg of protein, µM of pyruvate formed/min/mg of protein. 
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Serum Heart Serum Heart Serum Heart 
Normal 0.56± 0.08a 0.92±0.1a 29.6±8.9ab 0.62±0.11ab 0.19±0.04a 2.7± 0.13ab 
ISO 0.76±0.05b 1.38±0.1b 24.7±2.5a 0.53±0.09a 0.13±0.009b 2.2± 0.09a 
DB(100)+ISO 0.69±0.05ab 1.16±0.13ab 25.6±2.1a 0.97±0.21b 0.21±0.01ab 2.4± 0.17ab 
DB(200)+ISO 0.64±0.03ab 1.14±0.02ab 37.5±7.5b 0.89±0.26ab 0.35±0.09ab 2.5± 0.19b 
DG 10 mg/kg 0.72±0.03ab 1.24±0.09ab 28.0±5.9ab 0.48±0.05a 0.24±0.01ab 2.3± 0.17ab 
DG 20 mg/kg 0.57± 0.05a 1.14±0.13ab 40.9±13.9b 0.6±0.05ab 0.22±0.02ab 2.5± 0.17ab 
Values are mean ± S.D. (n=6). A significant difference was observed between different groups using One 
Way ANOVA followed by DMRT. Values with different letters like a,b, ab,c of the same column are 




Effect of D.B. on lipid profiles 
Lipids play an important role in cardiovascular disease, but their accumulation can lead to 
atherosclerosis and lead to ischemic heart disease and peripheral vascular disease. The increased risk of 
atherosclerosis is always associated with high levels of total cholesterol, low-density lipoproteins, very 
low-density lipoproteins, and low-density lipoproteins (Panda et al., 2014). Table 5 shows the cholesterol 
curve. Compared to normal animals, the ISO-induced group of animals resulted in increased levels of 
total cholesterol (T.C.), triglycerides (T.G.L.) and LDL, while the HDL level decreased (p <0.05). 
(Subasini., 2019) Similar results were observed. It was observed that the pretreatment animal group 
significantly reversed the lipid profile to normal levels (p<0.05). Those results can be seen in Table 5.  
 
Table 5: Effect of D.B. & diosgenin on lipid profile in ISO induced MI in 
rats 
Table 4. Effect of D.B. & diosgenin on enzymatic antioxidant in ISO induced MI in rats 
Groups Catalase  SOD GPX GST 
Normal 61.2 ± 1.7b 1.0 ± 0.37b 1.18±0.1b 132.1±15.3b 
ISO 16.0 ± 3.2a 0.57 ± 0.08a 0.88 ± 0.1a 72.8 ±7.8a 
DB(100)+ISO 32.7± 10.1ab 0.89 ± 0.08ab 1.22±0.21b 107.8±24.6ab 
DB(200)+ISO 60.9 ± 9.8b 1.07 ± 0.35b 1.22±0.21b 135.1± 13.2b 
DG 10 (mg/kg) 59.6 ± 9.4b 1.02 ± 0.38b 1.21±0.09b 132.6± 16.3b 
DG 20 (mg/kg) 60.4 ± 11.6b 0.94 ± 0.25ab 1.18±0.12b 132.4± 15.8b 
Values are mean ± S.D. (n=6). A significant difference was observed between different groups 
using One Way ANOVA followed by DMRT. Values with different letters like a,b, ab of the same 
column are differed significantly (p<0.05).Note: Activity of catalase, S.O.D., GPx and G.S.T. are 
represented as nM of H2O2consumed/min/mg of protein, Units/mg of protein, µM of G.S.H. 
consumed/min/mg of protein, nM of CDNB conjugated/min/mg of protein.  
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Groups Cholesterol Triacylglycerol LDL HDL 
Normal 140.0±5.2ab 125.9 ± 11.1ab 107.9±0.9ab 18.3± 3.1bc 
ISO 143.2±13.8b 143.2 ± 14.7b 117.1±11.6b 13.9± 1.3a 
DB(100)+ISO 157.9±13.1b 142.3 ± 30.0b 117.9±4.1b 16.4±3.0abc 
DB(200)+ISO 105.0±11.7a 102.1 ± 12.1ab 76.2±6.3a 14.7± 2.3ab 
DG 10 mg/kg 139.0±10.9ab 141.7 ± 10.5b 111.8±7.1b 14.2± 2.1a 
DG 20 mg/kg 127.2±8.9ab 85.2 ± 12.9a 88.2±3.5a 19.4± 2.8c 
Values are mean ± S.D. (n=6). A significant difference was observed between 
different groups using One Way ANOVA followed by DMRT. Values with 
different letters like a,b,ab,c,d of same column are differ significantly (p<0.05). 
 
Conclusion 
In conclusion, this study demonstrated that D.B and diosgenin significantly reduced isoprenaline-induced 
myocardial infarction injury in rats. This effect is related to a reduction in cardiac markers, cholesterol 
profile, and antioxidant research. However, more research is needed to understand the exact mechanism 
by which diosgenin inhibits oxidative stress in heart tissue damaged by myocardial infarction. The results 
of this study indicate that the cholesterol-lowering properties of diosgenin may have the potential to 
prevent and control cardiovascular disease. 
 
Conflict of interest 




1. Ahmed, Z., Chishti, M.Z., Johri, R.K., Bhagat, A., Gupta, K.K., Ram, G., 2009. 
Antihyperglycemic and antidyslipidemic activity of aqueous extract of Dioscorea bulbifera 
tubers. pp.63-72. 
2. Ellman, G.L., 1959. Tissue sulfydril groups. Arch BiochemBiophys. 82, 70-71. 
3. Farvin, K.,H., Anandan,. R, Kumar, S.H., Shiny, K.S., Sankar, T.V., Nair, P.G.. Protective effect of 
squalene on changes in lipid profile in experimentally induced myocardial infarction in rats. J 
Med Food. 2006; 9:531–6 
4. Ghosh, S., Derle, A., Ahire, M., More, P., Jagtap, S., 2013. Phytochemical analysis and free 
radical scavenging activity of medicinal plants Gnidiaglauca and Dioscorea bulbifera .PlosOne. 
8(12), e82529. 
5. Kakkar, P., Das, B., Viswanathan, P.N., 1984. A modified spectrophotometric assay of S.O.D. 
Indian J. Biochem. Biophys. 21, 130–132. 
6. Karthick M, Prince PS. Preventive effect of rutin, a bioflavonoid on lipid peroxides and 
antioxidants in isoproterenol-induced myocardial infarction in rats. J Pharm Pharmacol. 
2006;58:701–7. 
7. King, J., 1965a. The dehydrogenase or oxidoreductase. Lactate dehydrogenase. In:  Practical 
Clinical Enzymology. Nostrand Co., London. P 106. 
8. Kumar, V., Babu, V., Nagarajan, K., Machawal, L., Bajaj, U., 2015. Protective effects of 
Centellaasiatica against isoproterenol-induced myocardial infarction in rats. Biochemical, 
mitochondrial and histological findings. J. Phytopharmacol. 4, 80–86. 
Drugs and Cell Therapies in Hematology (ISSN: 2281-4876)   




9. Mohun, and Cook., 1957. Simple methods for measuring serum levels of the glutamate 
oxaloacetate and glutamic pyruvate transaminase in the routine laboratory. J. Clin. Pathol.10, 
337–339.  
10. Moron, M.S., Depierre, J.W., Mannervik, B., 1979. Levels of glutathione,  glutathione reductase 
and glutathione s-transferase activities in rat lung and liver. Biochim. Biophys. Acta. 582, 67–78. 
11. Narula, A., Kumar, S., Srivastava, P.S., 2007. Genetic fidelity of in vitro regenerants, 
encapsulation of shoot tips and high diosgenin content in Dioscorea bulbifera L., a potential 
alternative source of diosgenin. Biotechnol. Lett. 29(4),  623–629. 
12. Ohkawa, H., Ohishi, N., Yagi, K., 1979. Assay for lipid peroxides in animal tissues by the 
thiobarbituric acid reaction. Anal. Biochem. 95, 351–358. 
13. Okinaka, S., Kumagai, H., Ebashi, S.H., 1961. Serum creatine phosphokinase.  Activity in 
progressive muscular dystrophy and neuromuscular diseases. Arch.  Neurol. 4, 520-525. 
14. Rotruck, J.T., Pope, A.L., Ganther, H.E., 1973. Selenium: Biochemical role as a  component of 
glutathione peroxidase. Science. 179, 588–590. 
15. Saravanan, S., Ramachandran, S., SujaRajapandian, Subasini, U., Victor Rajamanickam, G., 
Dube,y G.P.,  2011. "Anti-Atherogenic Activity of Ethanolic fraction of Terminalia arjuna bark on 
Hypercholesterolemic rabbits", Evidence-Based Complementary and alternative medicine. 2 doi: 
10.1093/ecam/neq003:  1-8. 
16. Saravanan, S., Ramachandran, S., SujaRajapandian, Subasini, U., Victor Rajamanickam, G., 
Dube,y G.P.,  2011. "Anti-Atherogenic Activity of Ethanolic fraction of Terminalia arjuna bark on 
Hypercholesterolemic rabbits", Evidence-Based Complementary and alternative medicine., 2 doi: 
10.1093/ecam/neq003:  1-8. 
17. Sathish, V., Ebeneza, K.K., Devak, T., 2003. Synergistic effect of nicorandil and amlodipine on 
lysosomal hydrolases during experimental myocardial infarction in rats. Biomed. Pharmacol. 57, 
309–313. 
18. Sinha, K.A., 1972. Colourimetric assay of catalase. Anal. Biochem. 47, 389–394. 
19. Subasini U, Mohamed M. Shabi, Gayathri K, Dhevi R, N.Ramakrishnan, Victor   G. 
Rajamanickam, G.P. Dubey., 2009.  Phytochemical evaluation with hypoglycaemic and 
antioxidant activity of Tribulus terrestris Linn. International Journal of Biomedicine. 29 (2):  121-
127 
20. Subasini Uthirapathy., 2019.  Novel Biomarkers of Atherogenic diet-induced dyslipidemia and 
metabolic syndrome suppressed by Terminalia Arjuna., IJPSR. 10(5): 2528-2536. DOI: 
10.13040/IJPSR.0975-8232.10(5).2528-36 
21. Subasini, U., R., Sundaraganapathy, M.P. Narmadha, Victor   G. Rajamanickam, G.P. Dubey. 
2009. "Cardio-protective effect of polyherbal formulation in isoproterenol induced cardiotoxicity" 
International Journal of Pharma Research. 2(3): 75-82. 
22. Subasini, U., S.,Thenmozhi, S., Mohamed shabi, Sasikala, C., Nina Varghese, Victor 
Rajamanickam, G., and Dubey, G.P., 2014.  Comparative antioxidant evaluation of three Indian 
cardio-protective medicinal plants in in-vitro studies, International Journal of Integrative Medical 
Sciences, Int J IntgMed Sci. 1(2):21-29, 2394 – 4137      
23. Suchalatha, S., Shyamala Devi, C.S., 2004. Protective effect of Terminalia chebula against 
experimental injury induced by Isoproterenol. Ind. J. Exp. Biol. 42, 174-178. 
24. Vimal, V., Devaki, T., 2004. Linear furanocoumarin protects rat myocardium against 
lipidperoxidation and membrane damage during experimental myocardial injury. Biomed. 
Drugs and Cell Therapies in Hematology (ISSN: 2281-4876)   




Pharmacother. 58, 393. 
25. Wexler BC. Myocardial infarction in young vs old male rats: Pathophysiologic changes. Am 
Heart J. 1978; 96:70–80. 
26. Wexler, B.C., Greenberg, B.P., 1978. Protective effects of clofibrate on Isoproterenol induced 
myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. Atherosclerosis. 29, 373–
395. 
27. Zhang, J., Herman, E. H., Robertson, D. G., Reily, M. D., Knapton, A., Ratajczak, H.  V., 2006. 
Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III 
SK & F 95654 in spontaneously hypertensive rats. Toxicol. Pathol. 34, 152–163. 
28. Zlatkis, A., Zak, B., Boyle, A.J., 1953. A new method for the direct determination of serum 
cholesterol. J. Clin. Med. 41, 486–492. 
 
 
View publication stats
